TRIO Antikörper (AA 1961-2070)
Kurzübersicht für TRIO Antikörper (AA 1961-2070) (ABIN563257)
Target
Alle TRIO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1961-2070
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant TRIO.
-
Sequenz
- ERKSSSLKRR HYVLQELVET ERDYVRDLGY VVEGYMALMK EDGVPDDMKG KDKIVFGNIH QIYDWHRDFF LGELEKCLED PEKLGSLFVK HERRLHMYIA YCQNKPKSEH
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- TRIO (NP_009049, 1961 a.a. ~ 2070 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma." in: Tumour biology, (2015) (PubMed).
: "The Rho-guanine nucleotide exchange factor Trio controls leukocyte transendothelial migration by promoting docking structure formation." in: Molecular biology of the cell, Vol. 23, Issue 15, pp. 2831-44, (2012) (PubMed).
: "Tara up-regulates E-cadherin transcription by binding to the Trio RhoGEF and inhibiting Rac signaling." in: The Journal of cell biology, Vol. 193, Issue 2, pp. 319-32, (2011) (PubMed).
-
-
- TRIO (Triple Functional Domain Protein (TRIO))
-
Andere Bezeichnung
- TRIO
-
Hintergrund
-
Full Gene Name: triple functional domain (PTPRF interacting)
Synonyms: FLJ42780,tgat -
Gen-ID
- 7204
-
NCBI Accession
- NM_007118
Target
-